NCT03207477 (PrmvsionSuiv) is a NA clinical trial of Visual acuity measurement in Visual Disorder, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT03207477?

NCT03207477 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT03207477?

Interventions in NCT03207477: Visual acuity measurement.

What condition does NCT03207477 study?

NCT03207477 studies Visual Disorder.

Is NCT03207477 still recruiting?

NCT03207477 is currently terminated. Last updated 13 August 2021.

Last reviewed 2021-08-13 · How we verify

NCT03207477: PrmvsionSuiv

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Premavision Cohort Follow-up

Terminated NA Last updated 13 August 2021

What this trial tests

NA trial testing Visual acuity measurement in Visual Disorder in 37 participants. Terminated before completion.

Timeline

20 November 2017

Primary endpoint
30 June 2020

30 June 2021

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	37
Start date	20 November 2017
Primary completion	30 June 2020
Estimated completion	30 June 2021
Sites	1 location across France

Drugs / interventions tested

Visual acuity measurement

Conditions studied

Visual Disorder — all drugs for Visual Disorder →

Sponsor

Central Hospital, Nancy, France

Who can join

Adults 18 Months to 7, any sex, with Visual Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aim at following a cohort of prematurely born infants at 18 months corrected age, 4 and 7 years of age. This cohort had an evaluation of visual maturation at term equivalent age (TEA) with factors associated with impaired visual maturation. (PREMAVISION-CLinicalTrials.gov ID: NCT02890251). In this follow-up study, prematurely born infants vision will be compared to term born infants matched for postnatal age.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Visual acuity measurement

Trials testing the same drug.

NCT05366543 — Errors of Refraction Among Primary School Children · unknown

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03207477 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 13 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03207477.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing